Mentari Therapeutics, Inc.

MTRI · NASDAQ · Healthcare / Biotechnology

18.60USD

Price History

Full chart

Market Stats

Open19.02

Day Range18.40 – 20.00

52-Week Range5.75 – 23.30

Volume11.90K

Market Cap1.08B

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

50-Day Avg14.22

200-Day Avg12.28

About

Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Gregory J. Divis Jr.
Headquarters1625 North Market Blvd., Sacramento, CA, United States, 95834, USA
Websitehttps://www.mentaritx.com

Leadership

Mr. Gregory J. Divis Jr.CEO & Director · b. 1967
Ms. Keri Lantz CPATreasurer · b. 1975

Earnings

Report Date	Dec 31, 2013	Mar 31, 2014	Jun 30, 2014	Sep 30, 2014	Dec 31, 2014	Mar 31, 2015	Jun 30, 2015	Sep 30, 2015	Dec 31, 2015	Mar 31, 2016	Jun 30, 2016	Sep 30, 2016	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	Mar 31, 2018	Sep 13, 2018	Nov 12, 2018	Feb 12, 2019	May 15, 2019	Sep 19, 2019	Nov 8, 2019	Feb 14, 2020	May 14, 2020	Sep 8, 2020	Nov 13, 2020	Feb 11, 2021	May 13, 2021	Sep 24, 2021	Nov 10, 2021	Feb 15, 2022	May 13, 2022	Sep 23, 2022	Nov 14, 2022	Feb 20, 2023	May 11, 2023	Nov 15, 2023	Feb 13, 2024	May 14, 2024	Nov 15, 2024	Feb 12, 2025	May 13, 2025	Sep 25, 2025	Nov 13, 2025	Feb 12, 2026	May 18, 2026	Sep 10, 2026	Nov 6, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	-175.06	-453.05	-453.79	-242.13	-2012.69	-5281.58	-4217.64	-1556.80	-159.25	-754.62	-1072.91	-73.26	-1247.52	-135.91	-1803.62	-182.85	-1511.78	-1831.90	-249.52	-209.86	-1940.13	-2528.74	-3056.28	-2818.78	-2430.86	-1998.69	-1597.45	-1537.97	-1413.42	-2054.22	-2023.89	-1233.29	-1546.44	-1228.02	-60476.58	-81.10	-182.66	-12.01	-152.44	-37.08	-35.84	-27.06	-36.45	-19.35	-8.93	-4.37	-5.13	-7.33	-14.34	-4.26
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap1.08B

Enterprise Value1.05B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.00

Price / Book0.00

Revenue (TTM)0

Gross Profit (TTM)0

Profit Margin0.00%

Operating Margin0.00%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding58.30M

Shares Float0

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 1 analysts

Strong Buy
1